Health Ministry Halts Use of Specific Similac Batch After Complaint
Israel's Ministry of Health announced Sunday that it has ordered a halt to the use of a specific batch of Similac infant formula intended solely for hospitals. The decision follows a single, isolated complaint received Saturday evening regarding batch number 89203N201.
As a precautionary measure, the ministry stated that the affected batch will not be distributed or sold to the public, as it is exclusively supplied to hospitals. The ministry emphasized that this is an isolated incident with no reports of adverse health effects linked to the formula. The manufacturer, Abbott, is reportedly working to provide an alternative batch to hospitals.
The directive applies only to this specific batch, and there are no restrictions on other Similac batches currently in circulation.
The same event, reported separately by each outlet. Open a few to compare what different newsrooms emphasize — and what they leave out.
Not the same event — other stories that share this one’s people, places, or theme: background, reactions, and follow-ups.
